Citigroup analyst Patrick Donnelly upgrades Bio-Techne (NASDAQ:TECH) from Neutral to Buy and raises the price target from $81.25 to $100.
Microsoft CEO Has ‘No Love’ For Console Exclusives, Blames Sony; District Judge Says ‘It’s Hard’ To Decide On Activision Tie-Up
Microsoft Corp (NASDAQ: MSFT) CEO Satya Nadella has placed the blame for the existence of console exclusives on Sony Group Corp.